Epsilon Healthcare Limited Stock

Equities

EPN

AU0000137598

Pharmaceuticals

Market Closed - Australian S.E. 06:37:33 2023-12-17 pm EST 5-day change 1st Jan Change
0.024 AUD -.--% Intraday chart for Epsilon Healthcare Limited -.--% -.--%
Sales 2021 5.5M 3.58M Sales 2022 7.11M 4.63M Capitalization 7.51M 4.89M
Net income 2021 -9M -5.86M Net income 2022 -13M -8.47M EV / Sales 2021 3.26 x
Net Debt 2021 2.1M 1.37M Net Debt 2022 2.34M 1.52M EV / Sales 2022 1.38 x
P/E ratio 2021
-1.48 x
P/E ratio 2022
-0.38 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 60.39%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.02
Extreme 0.016
0.03
3 years
0.02
Extreme 0.016
0.21
5 years
0.02
Extreme 0.016
0.60
10 years
0.02
Extreme 0.016
1.15
More quotes
Managers TitleAgeSince
Chief Executive Officer - Nov. 20
Comptroller/Controller/Auditor - -
Corporate Secretary 60 22-12-22
Members of the board TitleAgeSince
Chairman - 16-08-28
Director/Board Member - 22-10-26
Chairman - 22-10-27
More insiders
Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Company’s segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Company’s subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.
More about the company